These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9405253)

  • 1. Zinc dependent activation of cAMP-specific phosphodiesterase (PDE4A).
    Percival MD; Yeh B; Falgueyret JP
    Biochem Biophys Res Commun; 1997 Dec; 241(1):175-80. PubMed ID: 9405253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of the human PDE4A catalytic domain (PDE4A330-723) expressed in Sf9 cells.
    Lario PI; Bobechko B; Bateman K; Kelly J; Vrielink A; Huang Z
    Arch Biochem Biophys; 2001 Oct; 394(1):54-60. PubMed ID: 11566027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of purified human phosphodiesterase 4A expressed in yeast cell GL62 by ciclamilast, piclamilast, and rolipram.
    Chen JC; Chen JQ; Xie QM; Zhu YL
    Acta Pharmacol Sin; 2004 Sep; 25(9):1171-5. PubMed ID: 15339393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant expression of a type IV, cAMP-specific phosphodiesterase: characterization and structure-function studies of deletion mutants.
    Kovala T; Sanwal BD; Ball EH
    Biochemistry; 1997 Mar; 36(10):2968-76. PubMed ID: 9062127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed characterization of a purified type 4 phosphodiesterase, HSPDE4B2B: differentiation of high- and low-affinity (R)-rolipram binding.
    Rocque WJ; Holmes WD; Patel IR; Dougherty RW; Ittoop O; Overton L; Hoffman CR; Wisely GB; Willard DH; Luther MA
    Protein Expr Purif; 1997 Mar; 9(2):191-202. PubMed ID: 9056484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of a catalytic zinc binding site in Escherichia coli L-threonine dehydrogenase by site-directed mutagenesis of cysteine-38.
    Johnson AR; Chen YW; Dekker EE
    Arch Biochem Biophys; 1998 Oct; 358(2):211-21. PubMed ID: 9784233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase.
    Fisher DA; Smith JF; Pillar JS; St Denis SH; Cheng JB
    Biochem Biophys Res Commun; 1998 May; 246(3):570-7. PubMed ID: 9618252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human recombinant phosphodiesterase 4B2B binds (R)-rolipram at a single site with two affinities.
    Rocque WJ; Tian G; Wiseman JS; Holmes WD; Zajac-Thompson I; Willard DH; Patel IR; Wisely GB; Clay WC; Kadwell SH; Hoffman CR; Luther MA
    Biochemistry; 1997 Nov; 36(46):14250-61. PubMed ID: 9369498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of human cAMP-specific phosphodiesterase activity and high affinity rolipram binding in yeast.
    Torphy TJ; Stadel JM; Burman M; Cieslinski LB; McLaughlin MM; White JR; Livi GP
    J Biol Chem; 1992 Jan; 267(3):1798-804. PubMed ID: 1309798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitution studies of the second divalent metal cation requirement of protein tyrosine kinase CSK.
    Sun G; Budde RJ
    Biochemistry; 1999 Apr; 38(17):5659-65. PubMed ID: 10220355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity Ni2+ binding selectively promotes binding of Helicobacter pylori NikR to its target urease promoter.
    Zambelli B; Danielli A; Romagnoli S; Neyroz P; Ciurli S; Scarlato V
    J Mol Biol; 2008 Nov; 383(5):1129-43. PubMed ID: 18790698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells.
    Zhu B; Kelly J; Vemavarapu L; Thompson WJ; Strada SJ
    Biochem Pharmacol; 2004 Aug; 68(3):479-91. PubMed ID: 15242814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual inhibition of human type 4 phosphodiesterase isostates by (R, R)-(+/-)-methyl 3-acetyl-4-[3-(cyclopentyloxy)-4-methoxyphenyl]-3- methyl-1-pyrrolidinecarboxylate.
    Tian G; Rocque WJ; Wiseman JS; Thompson IZ; Holmes WD; Domanico PL; Stafford JA; Feldman PL; Luther MA
    Biochemistry; 1998 May; 37(19):6894-904. PubMed ID: 9578576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor.
    Collado MC; Beleta J; Martinez E; Miralpeix M; Domènech T; Palacios JM; Hernández J
    Br J Pharmacol; 1998 Mar; 123(6):1047-54. PubMed ID: 9559885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of sphingomyelinase from Bacillus cereus by Zn2+ hitherto accepted as a strong inhibitor.
    Fujii S; Itoh H; Yoshida A; Higashi S; Ikezawa H; Ikeda K
    Arch Biochem Biophys; 2005 Apr; 436(2):227-36. PubMed ID: 15797235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of PDE4 structure on inhibitor selectivity across PDE families.
    Ke H
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S24-7. PubMed ID: 15224132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family.
    McPhee I; Pooley L; Lobban M; Bolger G; Houslay MD
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):965-74. PubMed ID: 7575434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CHO-K1 cells stably expressing PDE-IV enzymes. Whole-cell cAMP determinations vs broken-cell enzymatic assays.
    Pon DJ; Plant M; Tkach J; Boulet L; Muise E; Allen RA; Rodger IW
    Cell Biochem Biophys; 1998; 29(1-2):159-78. PubMed ID: 9631244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of a mutation in phosphodiesterase type 4 that alters both inhibitor activity and nucleotide selectivity.
    Herman SB; Juilfs DM; Fauman EB; Juneau P; Menetski JP
    Mol Pharmacol; 2000 May; 57(5):991-9. PubMed ID: 10779384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.